Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
September 5, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for November 3, 2006 Subscribe to this News Feed     Subscribe to this Podcast Feed  
 

Day of Discovery: Powerful Effects of Resveratrol Revealed in Online Slide Show Presented by Longevinex

Longevinex, the maker of the first red wine pill shown to activate the Sirtuin 1 gene, presents an online slide show to herald recent announcement that, for the first time, resveratrol has been shown to enhance the quality and quantity of life of a warm-blooded animal.

(PRWEB) November 3, 2006 -- Longevinex (www.longevinex.com), maker of the world's first resveratrol dietary supplement proven to activate the Sirtuin 1 DNA-repair gene, has unveiled an online slide show that heralds a newly published ground breaking study showing for the first time that resveratrol reduces mortality in warm-blooded animals. The online slide show is available at www.longevinex.com

Scientists have been waiting for this study ever since it was reported in 2003 that resveratrol, known as a red wine molecule, prolongs the life of yeast cells. Since then, resveratrol has been shown to increase the longevity of fruit flies, roundworms and cold-water fish. Now researchers at the National Institutes on Aging report that resveratrol not only significantly reduces mortality in mice but also enhances the quality of life and reverses the formation of fatty deposits in the liver. Aged mice given resveratrol still retained their physical balance and coordination.

Calorie restriction has been shown to prolong the life of many species of life, and resveratrol is considered a molecular mimic of calorie restriction via its ability to activate the Sirtuin 1 DNA repair gene.

Longevinex utilizes Licaps (Capsugel) technology to encapsulate resveratrol in an airtight capsule. The ingredients in Longevinex are never exposed to light, heat or oxygen during manufacture. Independent studies show Longevinex/Licaps capsules retain their labeled resveratrol content, 40 milligrams of trans resveratrol, for up to 2 years without significant degradation. To view the slide show, go to www.longevinex.com

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/Q291cC1Db3VwLUNvdXAtQ291cC1NYWduLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


Other Releases by this Member
OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
WILLIAM SARDI
Longevinex (Resveratrol Partners LLC)
909 596 9507
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright